HR2483119th CongressWALLET

SUPPORT for Patients and Communities Reauthorization Act of 2025

Sponsored By: Representative Guthrie

Became Law

Summary

Reauthorizes and funds a broad federal response to substance use prevention, treatment, and recovery. It updates and extends programs from overdose surveillance to fetal alcohol spectrum disorder prevention and raises authorized funding for prevention, treatment, workforce, and recovery supports.

Show full summary
  • Families and children — Funds prenatal and postnatal health at $4.3 million per year and creates a Fetal Alcohol Spectrum Disorder program with $12.5 million per year for prevention, screening, training, and coordinated services across health, child welfare, education, and justice systems.
  • People with substance use disorders and communities — Authorizes $505.6 million per year for overdose and substance prevention grants, broadens surveillance beyond opioids to emerging substances, and strengthens treatment and recovery supports including expanded residential programs and workforce incentives.
  • Health workers and crisis systems — Raises first responder training to $57 million per year, expands prescriber training to include podiatric and dental medicine, and requires FDA, HHS, and GAO studies and guidance on opioid assessment, at-home drug disposal, and 9-8-8 cybersecurity.

Bill Overview

Analyzed Economic Effects

13 provisions identified: 13 benefits, 0 costs, 0 mixed.

More overdose training for first responders

The law raises funding for first responder training to $57 million each year for 2026–2030. Training covers overdose and other drug‑related emergencies. This supports nationwide public safety and emergency response.

Broader overdose tracking and prevention

The law expands grants to track and prevent overdoses from any drug, not just opioids. It authorizes about $505.579 million each year for 2026–2030 for overdose detection and prevention. States and Tribes can help people access legal drug test strips. HHS must publish guidance within one year on safe at‑home drug disposal. A federal work group on fentanyl contamination gives yearly recommendations and ends September 30, 2030. Infection‑monitoring programs tied to drug use continue through 2030.

More help for kids facing trauma

The National Child Traumatic Stress Initiative gets $98.887 million each year for 2026–2028 and $100 million for 2029–2030. The law also raises trauma monitoring to $9 million a year for 2026–2030. The trauma‑informed care task force adds the Administration for Community Living, includes disability providers, and runs through 2030.

More support for mothers in recovery

Residential treatment for pregnant and postpartum women is authorized at $38.931 million each year for 2026–2030. Applicants must include a services plan and may describe outreach to affected women. Prenatal and postnatal health activities are authorized at $4.25 million each year for 2026–2030.

Stronger support for addiction treatment workers

Loan repayment for the addiction treatment workforce is authorized at $40 million each year for 2026–2030. Mental and behavioral health training grants continue through 2030. Peer support technical assistance doubles to $2 million a year for 2026–2030, with a regional center that ends September 30, 2030 and an evaluation due within four years.

Stronger cybersecurity for the 9-8-8 line

The 9‑8‑8 suicide and crisis line gets new cybersecurity protections. Funded network operators and crisis centers must report cyber incidents and vulnerabilities. The Government Accountability Office must study risks and report within 180 days.

More help for community recovery groups

Building Communities of Recovery grants rise to $17 million per year for 2026–2030. Comprehensive Opioid Recovery Centers must show they can provide services, including through referrals or contracts, and report how these arrangements work. That program is authorized through 2030.

Easier access to addiction medicines

Pharmacies can deliver certain Schedule III–V drugs to clinicians for injection or implantation in maintenance or detox care, or when a drug has special FDA safety rules. The law recognizes addiction medicine as a provider specialty. HHS must update grant rules within one year so any FDA‑approved or authorized overdose reversal drug can be used. HHS will review the schedule for buprenorphine‑naloxone products and may request changes.

Job training help during recovery

CAREER Act grants are authorized at $12 million each year for 2026–2030. Programs can use up to 5% of grant funds for participant transportation to work, training, or treatment visits. Outcome reporting is aligned with workforce measures. Authorities to address opioid‑related workforce impacts continue through 2030.

More prevention help for students

Schools and consortia can apply to serve more youth, including youth at increased risk for substance misuse. Grants must include a plan to keep work going after funding ends. The law authorizes $10 million for 2026, $12 million for 2027, $13 million for 2028, $14 million for 2029, and $15 million for 2030.

New FASD prevention and services

The law creates a program to prevent and address Fetal Alcohol Spectrum Disorders. It funds public and nonprofit groups to provide training, technical help, a resource hub, and services. It authorizes $12.5 million each year for 2026–2030.

Updates to prescribing and mental health tech

States choose their own PDMP vendors as long as they follow open standards. A prior model SUD records training rule is removed. More professional groups and curricula now count toward prescriber training (effective as if December 29, 2022). FDA must post within one year a plan to assess approved opioid pain drugs. The health IT office will hold a public roundtable within 180 days on EHRs for mental health and substance use care and report 180 days later. HHS will review State spending on first‑episode psychosis care and update guidance.

SAMHSA grants easier to find

HHS must hold a public meeting within one year to improve how SAMHSA funding opportunities are shared. HHS should improve Grants.gov and other outreach. A report on changes is due within one year after the meeting.

Sponsors & CoSponsors

Sponsor

Guthrie

KY • R

Cosponsors

  • Pettersen

    CO • D

    Sponsored 3/31/2025

Roll Call Votes

All Roll Calls

Yes: 366 • No: 57

house vote • 6/4/2025

On Passage

Yes: 366 • No: 57

View on Congress.gov

Related Bills

Back to Legislation

Take It Personal

Get Your Personalized Policy View

Create a free account to save research, track policy impacts, and unlock your personalized versions of these pages.

Already have an account? Sign in